Compounds > phthivazide
Page last updated: 2024-08-20

phthivazide and salinazid

phthivazide has been researched along with salinazid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Baltas, M; Bedos-Belval, F; Bernis, C; Camare, C; Carayon, C; Nègre-Salvayre, A; Vanucci-Bacqué, C1
Bajorath, J; Channar, PA; Hassan, S; Iqbal, J; Lecka, J; Nisa, ZU; Saeed, A; Sévigny, J; Shah, SJ1
Farias, AB; Henriques, RR; Junior, MAAL; Nogueira, TLDC; Quimas, JVF; Romeiro, NC; Santos, DC; Silva, LLD; Souza, ALF1

Other Studies

3 other study(ies) available for phthivazide and salinazid

ArticleYear
Synthesis, antioxidant and cytoprotective evaluation of potential antiatherogenic phenolic hydrazones. A structure-activity relationship insight.
    Bioorganic & medicinal chemistry, 2014, Aug-01, Volume: 22, Issue:15

    Topics: Animals; Antioxidants; Cell Survival; Cells, Cultured; Endothelial Cells; Hydrazones; Lipoproteins, LDL; Mice; Oxidation-Reduction; Phenols; Protective Agents; Structure-Activity Relationship; Superoxides; Ultraviolet Rays

2014
Isonicotinohydrazones as inhibitors of alkaline phosphatase and ecto-5'-nucleotidase.
    Chemical biology & drug design, 2017, Volume: 89, Issue:3

    Topics: 5'-Nucleotidase; Alkaline Phosphatase; Animals; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Enzyme Inhibitors; GPI-Linked Proteins; Humans; Isoniazid; Models, Molecular; Molecular Docking Simulation; Protein Conformation; Rats; Structure-Activity Relationship

2017
Acylhydrazones as isoniazid derivatives with multi-target profiles for the treatment of Alzheimer's disease: Radical scavenging, myeloperoxidase/acetylcholinesterase inhibition and biometal chelation.
    Bioorganic & medicinal chemistry, 2020, 05-15, Volume: 28, Issue:10

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Antioxidants; Biphenyl Compounds; Chelating Agents; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Electrophorus; Humans; Hydrazones; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Peroxidase; Picrates; Structure-Activity Relationship

2020